Discovery and functional characterization of small molecule inhibitors of SWI/SNFATPase activity in BRG1/SMARCA4-Deficient non small cell lung cancers

被引:0
|
作者
Jagani, Z. [1 ]
Chenail, G. [1 ]
Xiang, K. [1 ]
Bushold, G. [1 ]
Bhang, C. [1 ]
Li, A. [1 ]
Vattay, A. [1 ]
Gilbert, T. [1 ]
Zhu, J. [2 ]
Terranova, R. [3 ]
Dubost, V. [3 ]
Huet, F. [4 ]
Farley, D. [5 ]
Cantwell, J. [6 ]
Ruddy, D. [1 ]
Rakiec, D. [1 ]
Shirley, M. [1 ]
Elliott, G. [1 ]
Nakajima, K. [7 ]
Papillon, J. [7 ]
机构
[1] Novartis Inst BioMed Res, Oncol, Cambridge, MA USA
[2] Novartis Inst BioMed Res, Sci Data Analyt, Cambridge, MA USA
[3] Novartis Inst BioMed Res, Preclin Safety, Basel, Switzerland
[4] Novartis Inst BioMed Res, PreClin Safety, Cambridge, MA USA
[5] Novartis Inst BioMed Res, Chem Biol & Therapeut, Cambridge, MA USA
[6] Novartis Inst BioMed Res, Prot Sci, Emeryville, CA USA
[7] Novartis Inst BioMed Res, Global Discovery Chem, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
19 (PB-199
引用
收藏
页码:E23 / E23
页数:1
相关论文
共 50 条
  • [1] Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas
    Nambirajan, Aruna
    Dutta, Rimlee
    Malik, Prabhat Singh
    Bubendorf, Lukas
    Jain, Deepali
    ACTA CYTOLOGICA, 2021, 65 (01) : 67 - 74
  • [2] Immunophenotypical Analysis of SMARCA4 (BRG1) Deficient Non-Small Cell Lung Carcinoma Diagnosed on Cytology Specimens
    Ogunbona, Oluwaseun
    Lubin, Daniel
    Reid, Michelle
    Van Nostrand, Keriann
    Schneider, Frank
    Shi, Qiuying
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 257 - 258
  • [3] Immunophenotypical Analysis of SMARCA4 (BRG1) Deficient Non-Small Cell Lung Carcinoma Diagnosed on Cytology Specimens
    Ogunbona, Oluwaseun
    Lubin, Daniel
    Reid, Michelle
    Van Nostrand, Keriann
    Schneider, Frank
    Shi, Qiuying
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 257 - 258
  • [4] A BIZARRE CASE OF SMARCA4-DEFICIENT NON-SMALL CELL LUNG CANCER
    Boppana, Leela Krishna Teja
    Malik, Hanan
    CHEST, 2022, 162 (04) : 1632A - 1632A
  • [5] Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor
    Zhou, Ping
    Fu, Yiyun
    Tang, Yuan
    Jiang, Lili
    Wang, Weiya
    PEERJ, 2024, 12
  • [6] Discovery of selective BRM ( SMARCA2) ATPase inhibitors for the treatment of BRG1 (SMARCA4) mutant cancers
    Lee, Janice Y.
    Brooks, Nathan
    Antonakos, Brandon
    Perria, Bryan
    Langan, Candace
    Jones, Bonita D.
    Flack, Robert Stephen
    Li, Zhifang
    Terry, David
    Wallace, Ross
    Bondi, Robert
    Sis, Gereint
    Baracani, Ronee
    McVean, Maralee
    Kolakowski, Gabrielle
    Osimboni, Dayo
    Wilson, Kevin
    CANCER RESEARCH, 2024, 84 (06)
  • [7] SMARCA4-deficient non-small cell lung cancer: a case description and literature analysis
    Ye, Ruiyan
    Wu, Anqi
    Lin, Chen
    Li, Zhenning
    Feng, Yue
    Lin, Min
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2024, 14 (06) : 4215 - 4222
  • [8] Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer
    Liang, Xiyue
    Gao, Xianzheng
    Wang, Feng
    Li, Shenglei
    Zhou, Yashu
    Guo, Peng
    Meng, Yuanyuan
    Lu, Taiying
    CANCER MEDICINE, 2023, 12 (13): : 14171 - 14182
  • [9] SMARCA4-deficient non-small cell lung cancer with an EGFR mutation: A case report
    Sun, Lijun
    Fu, Qiong
    Chen, Lijiang
    Di, Meijuan
    Cao, Jianhua
    ONCOLOGY LETTERS, 2023, 26 (06)
  • [10] SMARCA4/BRG1 protein-deficient thoracic tumors dictate re-examination of small biopsy reporting in non-small cell lung cancer
    Mehta, Anurag
    Bansal, Divya
    Tripathi, Rupal
    Jajodia, Ankush
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2021, 55 (05) : 307 - 316